These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31925552)

  • 1. Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy: development of an online decision-making support system.
    Koo KC; Lee KS; Kim S; Min C; Min GR; Lee YH; Han WK; Rha KH; Hong SJ; Yang SC; Chung BH
    World J Urol; 2020 Oct; 38(10):2469-2476. PubMed ID: 31925552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the Long Short-Term Memory Artificial Neural Network-Based SCaP Survival Calculator for Prediction of Prostate Cancer Survival.
    Lim B; Lee KS; Lee YH; Kim S; Min C; Park JY; Lee HS; Cho JS; Kim SI; Chung BH; Kim CS; Koo KC
    Cancer Res Treat; 2021 Apr; 53(2):558-566. PubMed ID: 33070560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Precision Medicine: Development and Validation of A Machine Learning Based Decision Support System for Optimal Sequencing in Castration-Resistant Prostate Cancer.
    Lim H; Yoo JW; Lee KS; Lee YH; Baek S; Lee S; Kang H; Choi YD; Ham WS; Lee SH; Chung BH; Halawani A; Ahn JH; Koo KC
    Clin Genitourin Cancer; 2023 Aug; 21(4):e211-e218.e4. PubMed ID: 37076338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of preoperative artificial neural network based on blood biomarkers and clinicopathological parameters for predicting long-term survival of patients with gastric cancer.
    Que SJ; Chen QY; Qing-Zhong ; Liu ZY; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Li P; Zheng CH; Huang CM; Xie JW
    World J Gastroenterol; 2019 Nov; 25(43):6451-6464. PubMed ID: 31798281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing neural network models for early detection of cardiac arrest in emergency department.
    Jang DH; Kim J; Jo YH; Lee JH; Hwang JE; Park SM; Lee DK; Park I; Kim D; Chang H
    Am J Emerg Med; 2020 Jan; 38(1):43-49. PubMed ID: 30982559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer.
    Bhambhvani HP; Zamora A; Shkolyar E; Prado K; Greenberg DR; Kasman AM; Liao J; Shah S; Srinivas S; Skinner EC; Shah JB
    Urol Oncol; 2021 Mar; 39(3):193.e7-193.e12. PubMed ID: 32593506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an artificial neural network prognostic model after gastrectomy for gastric carcinoma: An international multicenter cohort study.
    Li Z; Wu X; Gao X; Shan F; Ying X; Zhang Y; Ji J
    Cancer Med; 2020 Sep; 9(17):6205-6215. PubMed ID: 32666682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural networks--a method for prediction of survival following liver resection for colorectal cancer metastases.
    Spelt L; Nilsson J; Andersson R; Andersson B
    Eur J Surg Oncol; 2013 Jun; 39(6):648-54. PubMed ID: 23514791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An artificial neural network to predict the outcome of repeat prostate biopsies.
    Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
    Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer.
    Kodama H; Hatakeyama S; Narita S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Narita T; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Arai Y; Habuchi T; Ohyama C
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1091-e1098. PubMed ID: 31575477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations.
    Stephan C; Xu C; Finne P; Cammann H; Meyer HA; Lein M; Jung K; Stenman UH
    Urology; 2007 Sep; 70(3):596-601. PubMed ID: 17688922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer.
    Zhao J; Sun G; Liao B; Zhang X; Armstrong CM; Yin X; Liu J; Chen J; Yang Y; Zhao P; Tang Q; Wang Z; Chen Z; Li X; Wei Q; Li X; Chen N; Gao AC; Shen P; Zeng H
    BJU Int; 2018 Dec; 122(6):994-1002. PubMed ID: 29772102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients.
    Stangl-Kremser J; Mari A; Suarez-Ibarrola R; D'Andrea D; Korn SM; Pones M; Kramer G; Karakiewicz P; Enikeev DV; Glybochko PV; Briganti A; Shariat SF
    Urol Oncol; 2020 Jun; 38(6):600.e9-600.e15. PubMed ID: 31953003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database.
    Hervás A; Pastor J; González C; Jové J; Gómez A; Casaña M; Villafranca E; Mengual JL; Muñoz V; Henriquez I; Muñoz J; Collado E; Clemente J
    Clin Transl Oncol; 2019 Jul; 21(7):900-909. PubMed ID: 30536208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
    Narita S; Nomura K; Hatakeyama S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Ohyama C; Arai Y; Nagashima K; Habuchi T
    Cancer Med; 2019 Nov; 8(15):6566-6577. PubMed ID: 31508900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive factor analysis of time to progression of castration-resistant prostate cancer after androgen deprivation therapy].
    Ji GJ; Huang C; Song G; Li XS; Song Y; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):657-662. PubMed ID: 28816284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
    Kodama H; Koie T; Oikawa M; Narita T; Tanaka T; Noro D; Iwamura H; Tobisawa Y; Yoneyama T; Hashimoto Y; Ohyama C
    Int Urol Nephrol; 2020 Apr; 52(4):671-679. PubMed ID: 31897875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameter selection for and implementation of a web-based decision-support tool to predict extubation outcome in premature infants.
    Mueller M; Wagner CL; Annibale DJ; Knapp RG; Hulsey TC; Almeida JS
    BMC Med Inform Decis Mak; 2006 Mar; 6():11. PubMed ID: 16509967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.
    Ahn HK; Lee KS; Kim D; Rha KH; Hong SJ; Chung BH; Koo KC
    Yonsei Med J; 2020 Aug; 61(8):652-659. PubMed ID: 32734728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer.
    Akamatsu S; Kubota M; Uozumi R; Narita S; Takahashi M; Mitsuzuka K; Hatakeyama S; Sakurai T; Kawamura S; Ishidoya S; Hoshi S; Ishida M; Mizuno K; Ogura K; Goto T; Terada N; Kobayashi T; Yamasaki T; Inoue T; Tsuchiya N; Ohyama C; Arai Y; Habuchi T; Morita S; Ogawa O
    Eur Urol Oncol; 2019 May; 2(3):320-328. PubMed ID: 31200847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.